Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.

Antimicrobial Agents and Chemotherapy
H RodeS Cywes

Abstract

Methicillin-resistant Staphylococcus aureus strains (MRSA) have become increasingly prevalent as nosocomial pathogens, especially in burn wounds. MRSA constituted 38% of all S. aureus isolates in our 25-bed burns unit despite the utilization of a combination of 1% silver sulfadiazine and 0.2% chlorhexidine as topical therapy. Mupirocin, a new antibiotic, has proved in vitro and in vivo to be highly effective in the treatment of MRSA infections. A prospective clinical trial with mupirocin ointment in MRSA burn wound infection was untertaken. Forty-five children with 59 discrete burn wounds and from whom MRSA were isolated were treated with 2% mupirocin ointment under occlusive dressings, applied twice daily for 5 days. The average burned area treated was 8% (range, 2 to 20%) of the total body surface area. The burn wounds were assessed clinically and bacteriologically daily. Mupirocin eliminated MRSA in all 59 wounds treated, with the maximum therapeutic response seen within 4 days. In three wounds, gram-negative organisms persisted after 5 days of topical therapy. Treatment was well tolerated by all children. We recommend that mupirocin in its present polyethylene glycol base should be used only on a selective basis, when curre...Continue Reading

References

Feb 26, 1977·Lancet·L D SabathB J Wilkinson
Jan 1, 1977·Journal of Clinical Pathology·G A AyliffeE J Lowbury
Jan 1, 1987·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Nov 1, 1985·Pediatric Infectious Disease·W R JarvisJ M Hughes
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
May 1, 1985·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Jun 1, 1985·Journal of Clinical Microbiology·C E HaleyP A Mackowiak
Aug 13, 1983·Lancet·J WuiteG Mellows
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·R W LaceyC Lincoln
Nov 29, 1984·The New England Journal of Medicine·C A BartzokasR S Croton
Sep 1, 1983·Antimicrobial Agents and Chemotherapy·J ChirifeE S Kohn
Oct 1, 1980·Annals of Internal Medicine·J E PeacockR P Wenzel
Jun 1, 1982·American Journal of Epidemiology·C C LinnemannJ L Staneck
Jan 1, 1982·The Journal of Antimicrobial Chemotherapy·R F Williams
Sep 1, 1982·Burns, Including Thermal Injury·D E BrunsR F Edlich

❮ Previous
Next ❯

Citations

Feb 1, 1996·Burns : Journal of the International Society for Burn Injuries·R K GangS C Sanyal
Jun 13, 1998·Burns : Journal of the International Society for Burn Injuries·N Cook
Jan 9, 1999·Burns : Journal of the International Society for Burn Injuries·M Prasanna, C Thomas
Feb 9, 1999·The Journal of Emergency Medicine·P M Williford
Sep 16, 1999·International Journal of Dermatology·P M de WetA J Millar
Jan 1, 1990·Society for Applied Bacteriology Symposium Series·B Cookson, I Phillips
Apr 15, 2006·Clinical Microbiology Reviews·Deirdre ChurchRobert Lindsay
Aug 28, 2010·Journal of Biomedicine & Biotechnology·T D J Heunis, L M T Dicks
Feb 12, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sathiamurthi PerumalBalaraman Madhan
Jun 18, 2011·The Medical Clinics of North America·Peter A Lio, Elaine T Kaye
Jun 15, 2010·Burns : Journal of the International Society for Burn Injuries·Jessie S GlasserClinton K Murray
Nov 17, 2009·Infectious Disease Clinics of North America·Peter A Lio, Elaine T Kaye
Aug 1, 1994·The Journal of Hospital Infection·J LoulergueC De Gialluly
Oct 1, 1993·Burns : Journal of the International Society for Burn Injuries·M J Vizcaino-AlcaideJ Rey-Calero
Oct 1, 1994·Burns : Journal of the International Society for Burn Injuries·I A Holder, S T Boyce
Aug 17, 2004·Infectious Disease Clinics of North America·Peter A Lio, Elaine T Kaye
May 4, 1999·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·E E UdoS C Sanyal
Jun 26, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Sanaâ Bouhali ZriouilKhalid Zerouali
Nov 25, 2016·Applied and Environmental Microbiology·Payel ChatterjeeHans Wildschutte
May 21, 2014·Antimicrobial Agents and Chemotherapy·Elisabeth M HaismaPeter H Nibbering
Nov 26, 2015·Antimicrobial Agents and Chemotherapy·Catlyn BlanchardPaul M Dunman
Jul 25, 2008·The Journal of Craniofacial Surgery·Priti P PatelSamuel T Rhee
Oct 30, 2003·The Cochrane Database of Systematic Reviews·Mark B LoebCindy Walker-Dilks
Jun 14, 2018·Frontiers in Microbiology·Andrew WagnerHans Wildschutte
Aug 28, 2018·Antimicrobial Resistance and Infection Control·Adebayo O ShittuAyodele O Olatimehin
Jan 8, 2021·PLoS Computational Biology·Bor KavčičTobias Bollenbach

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinics in Dermatology
W Winkelman, D Gratton
Journal of the American Academy of Dermatology
K A Pappa
Burns : Journal of the International Society for Burn Injuries
M J Vizcaino-AlcaideJ Rey-Calero
© 2022 Meta ULC. All rights reserved